Insights from 2024 ASCO® GI Annual Meeting


 

ASCO® GI 2024 Insights: "Emerging Data and Ongoing Trials With Zanzalintinib, a Novel Multitargeted TKI in CRC"

81 views
February 12, 2024
Comments 0
Login to view comments. Click here to Login